Identifying digital pathology imaging based biomarkers of checkpoint inhibitor response in non-small cell lung cancer

被引：0
|
作者：
Patkar, Sushant
Chen, Alex
Rajendran, Rahul
Basnet, Alina
Turkbey, Baris
Choyke, Peter L.
Harmon, Stephanie A.
Jamaspishvili, Tamara
机构：
[1] NCI, NIH, Bethesda, VA USA
[2] NCI, NIH, Bethesda, MD USA
[3] SUNY Upstate Med Univ, Syracuse, NY USA
[4] NCI, Mol Imaging Branch, NIH, Bethesda, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8530
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Biomarkers of immunotherapy in non-small cell lung cancer
    Wang, Lingling
    Hu, Yue
    Wang, Shengchao
    Shen, Jiali
    Wang, Xiaochen
    ONCOLOGY LETTERS, 2020, 20 (05)
  • [42] Emerging biomarkers in non-small cell lung cancer
    Greillier, L.
    ONCOLOGIE, 2012, 14 (05) : 316 - 319
  • [43] Resistance to immune checkpoint inhibitors in non-small cell lung cancer: biomarkers and therapeutic strategies
    Walsh, Robert J.
    Soo, Ross A.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [44] Survival and biomarkers for cachexia in non-small cell lung cancer receiving immune checkpoint inhibitors
    Murata, Daiki
    Azuma, Koichi
    Matsuo, Norikazu
    Murotani, Kenta
    Matama, Goushi
    Kawahara, Akihiko
    Sasada, Tetsuro
    Tokito, Takaaki
    Hoshino, Tomoaki
    CANCER MEDICINE, 2023, 12 (19): : 19471 - 19479
  • [45] Emerging biomarkers for neoadjuvant immune checkpoint inhibitors in operable non-small cell lung cancer
    Pradhan, Monika
    Chocry, Mathieu
    Gibbons, Don L.
    Sepesi, Boris
    Cascone, Tina
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (01) : 590 - 606
  • [46] Efficacy and clinicogenomic biomarkers of response to dual versus single agent checkpoint inhibitor therapy in untreated metastatic non-small cell lung cancer.
    Boiarsky, Daniel
    Hong, Lingzhi
    Ricciuti, Biagio
    Cooper, Alissa Jamie
    Saad, Maliazurina B.
    Elkrief, Arielle
    Di Federico, Alessandro
    Aminu, Muhammad
    Rinsurongkawong, Waree
    Lewis, Jeff
    Gibbons, Don Lynn
    Vaporciyan, Ara A.
    Le, Xiuning
    Lee, J. Jack
    Heymach, John
    Wu, Jia
    Schoenfeld, Adam Jacob
    Awad, Mark M.
    Zhang, Jianjun
    Vokes, Natalie I.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [47] Deep learning-based predictive biomarker for immune checkpoint inhibitor response in metastatic non-small cell lung cancer.
    Park, Sehhoon
    Ahn, Chang Ho
    Jung, Geunyoung
    Lee, Sarah
    Paeng, Kyunghyun
    Shin, Jiwon
    Yoo, Inwan
    Jung, Hyun Ae
    Sun, Jong-Mu
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Keunchil
    La Choi, Yoon
    Song, Sang-Yong
    Lee, Se-Hoon
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] Response to Checkpoint Inhibition in Non-Small Cell Lung Cancer with Molecular Driver Alterations
    Kauffmann-Guerrero, Diego
    Tufman, Amanda
    Kahnert, Kathrin
    Bollmann, Benjamin Alexander
    Reu, Simone
    Syunyaeva, Zulfiya
    Schneider, Christian
    Manapov, Farkhad
    Huber, Rudolf M.
    Golpon, Heiko
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (06) : 289 - 297
  • [49] Immune Checkpoint Modulation for Non-Small Cell Lung Cancer
    Soria, Jean-Charles
    Marabelle, Aurelien
    Brahmer, Julie R.
    Gettinger, Scott
    CLINICAL CANCER RESEARCH, 2015, 21 (10) : 2256 - 2262
  • [50] Immune checkpoint pathways in non-small cell lung cancer
    Chae, Young Kwang
    Arya, Ayush
    Iams, Wade
    Cruz, Marcello
    Mohindra, Nisha
    Villaflor, Victoria
    Giles, Francis J.
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (05)
12345